Literature DB >> 2889525

Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens.

A Columbano1, G M Ledda-Columbano, G Lee, S Rajalakshmi, D S Sarma.   

Abstract

Experiments were designed to determine whether liver cell proliferation induced by direct mitogens is as effective as compensatory cell proliferation consequent to previous cell loss, in supporting the growth of enzyme-altered islands in the liver induced by chemical carcinogens. Male Wistar rats were given injections of a single nonnecrogenic dose of N-methyl-N-nitrosourea or benzo(a)pyrene during the S phase following the administration of four different liver mitogens, namely, lead nitrate, ethylene dibromide, nafenopin, and cyproterone acetate, or during compensatory cell proliferation following partial hepatectomy or a necrogenic dose of CCl4. The carcinogen-altered hepatocytes were monitored as gamma-glutamyltransferase- or placental glutathione S-transferase-positive foci using a 2-wk promoting regimen consisting of 0.03% 2-acetylaminofluorene coupled with a necrogenic dose of CCl4. The results indicate that, unlike compensatory cell proliferation induced by partial hepatectomy or CCl4, the mitogen-induced cell proliferation did not result in a significant number of enzyme-altered islands, despite the fact that the extent of cell proliferation at the time of carcinogen administration, as monitored by the examination of labeled cells, is similar with both types of proliferative stimuli.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889525

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors.

Authors:  G H Lee
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 2.  Hepatocyte proliferation in stepwise development of experimental liver cell cancer.

Authors:  E Farber
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

3.  Hepatocyte proliferation induced by a single dose of a peroxisome proliferator.

Authors:  T Ohmura; G M Ledda-Columbano; R Piga; A Columbano; J Glemba; S L Katyal; J Locker; H Shinozuka
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  Dexamethasone inhibits induction of liver tumor necrosis factor-alpha mRNA and liver growth induced by lead nitrate and ethylene dibromide.

Authors:  G M Ledda-Columbano; A Columbano; A Cannas; G Simbula; K Okita; K Kayano; Y Kubo; S L Katyal; H Shinozuka
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

Review 5.  An overview of peroxisome proliferator-induced hepatocarcinogenesis.

Authors:  M S Rao; J K Reddy
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

Review 6.  Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis.

Authors:  H Yamasaki; V Krutovskikh; M Mesnil; A Columbano; H Tsuda; N Ito
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 7.  Lead toxicity: from overt to subclinical to subtle health effects.

Authors:  R A Goyer
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

Review 8.  Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis.

Authors:  G M Ledda-Columbano; P Coni; G Simbula; I Zedda; A Columbano
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 9.  Lead toxicity: current concerns.

Authors:  R A Goyer
Journal:  Environ Health Perspect       Date:  1993-04       Impact factor: 9.031

Review 10.  Concepts, labeling procedures, and design of cell proliferation studies relating to carcinogenesis.

Authors:  T L Goldsworthy; B E Butterworth; R R Maronpot
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.